Rephonic
Artwork for Lung Cancer Considered

Lung Cancer Considered

IASLC
Lung Cancer
Immunotherapy
Non-Small Cell Lung Cancer
Thoracic Oncology
Targeted Therapy
Clinical Trials
Osimertinib
Biomarker Testing
Molecular Testing
Small Cell Lung Cancer
Chemotherapy
EGFR
Liquid Biopsy
EGFR Mutation
IASLC World Conference On Lung Cancer
IASLC
Neoadjuvant Therapy
ASCO 2024
Chemoimmunotherapy
Egfr-Mutant Non-Small Cell Lung Cancer

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 co... more

PublishesTwice weeklyEpisodes419Founded7 years ago
Number of ListenersCategory
Science

Listen to this Podcast

Artwork for Lung Cancer Considered

Latest Episodes

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world... more

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world... more

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world... more

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of their careers. Dr. Sara Fra, Dr. Cassio Murilo Hida... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Lung Cancer Update
Lung Cancer UpdateDr. Neil Love
Two Onc Docs
Two Onc DocsSam and Karine
JTO Insights
JTO InsightsJTO Insights
Conversations in Lung Cancer Research
Conversations in Lung Cancer ResearchThoracic Oncology Group Of Australasia (TOGA)

Recent Guests

Miguel Gonzalez Velez
Oncólogo; affiliated with Hackensack University Medical Center
Hackensack University Medical Center
Episode: LCC in Spanish: WCLC 2026 Highlights
Jorge Alatorre
Oncólogo; afiliado con INER
Instituto Nacional de Enfermedades Respiratorias (INER)
Episode: LCC in Spanish: WCLC 2026 Highlights
Daniel Tan
Senior consultant at the National Cancer Centre Singapore and professor at Duke-NUS Medical School
National Cancer Centre Singapore; Duke-NUS Medical School
Episode: Live From WCLC 2026: Tuesday Highlights & Meeting Summary
Julia Rotow
Clinical director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute; Harvard Medical School
Episode: Live From WCLC 2026: Tuesday Highlights & Meeting Summary
Roy Herbst
Director of Dartmouth Cancer Center; associate dean for cancer programs; PI of Adaura
Dartmouth Hitchcock Medical Center; Adaura investigator
Episode: Live From WCLC 2026: Tuesday Highlights & Meeting Summary
Yun Fan
Professor, medical oncology
China (academic hospital)
Episode: LCC in Mandarin: WCLC 2026 Highlights
Zhengfei Zhu
Professor, thoracic surgery
China (academic hospital)
Episode: LCC in Mandarin: WCLC 2026 Highlights
Dongsheng Yue
Professor, radiation oncology
China (academic hospital)
Episode: LCC in Mandarin: WCLC 2026 Highlights
Alex Drilon
Chief of the Early Drug Development Service and the Carol Basick Loewenstein Chair at Memorial Sloan Kettering
Memorial Sloan Kettering Cancer Center
Episode: Live From WCLC 2026: Monday Highlights

Hosts

Narjust Florez
Host of Lung Cancer Considered; clinical researcher with affiliations at Harvard Medical School and IASLC; focuses on thoracic oncology and translational lung cancer biology.
Dr. Stephen Liu
Co-Host; physician-scientist specializing in hematology/oncology with leadership roles in thoracic oncology.

Reviews

4.6 out of 5 stars from 48 ratings
  • Episode on Immunotherapy

    Really enjoyed the conversation between these oncologist. They seem to be great doctors who really care for their patients are working for the best solutions they know of.

    It was also interesting to see their blind spots. The great thing about immunotherapy is slowly opening the door between integrative oncology and traditional oncology. These guys don’t get into it but they are asking the right questions.

    1) What can be combined with immunotherapy?

    2) What can be done to prevent side effec... more

    Apple Podcasts
    5
    TBobo
    United States4 years ago
  • Fantastic for doctors, nurses, patients

    Great conversations on all things lung cancer.

    Apple Podcasts
    5
    DrFLC
    United States6 years ago
  • :)

    great info!

    Apple Podcasts
    5
    yeoohaz
    United States6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Audience notes the mix of clinical data interpretation and real-world access issues.
Many appreciate practical takeaways and emphasis on biomarker-driven care.
Listeners praise expert clinical insight and balanced discussion of evolving therapies.
Guests are seen as credible, knowledgeable, and helpful for planning treatment and trials.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#140
Norway/Science
Apple Podcasts
#163
South Korea/Science
Apple Podcasts
#177
Brazil/Science
Apple Podcasts
#189
New Zealand/Science
Apple Podcasts
#203
Austria/Science
Apple Podcasts
#223
Japan/Science

Talking Points

Recent interactions between the hosts and their guests.

Live From WCLC 2026: Monday Highlights
Q: Could you walk us through the PFS data and why the trial did not meet its primary endpoint for progression-free survival?
Mountzios explained the 57% maturation and observed median PFS of 11.8 months versus 7.7 months with a hazard ratio of 0.81, but the p-value did not cross the predefined boundary, leading to the conclusion that the trial did not meet its primary endpoint despite a numerical benefit.
Live From WCLC 2026: Monday Highlights
Q: Outside of a trial, what drug are you going to prescribe to a ROS1 fusion-positive patient in the frontline setting?
Drilon indicated that Zytosamantib would be his preferred choice given its safety profile and CNS activity, suggesting it as a likely frontline option once approved, with a focus on improving quality of life and brain metastasis control,
The Global Fight Against Lung Cancer: A Conversation with WHO's José Luis Castro
Q: What lessons from HIV advocacy and treatment mobilization can inform lung cancer policy and patient engagement today?
The key lesson is the power of patient voices and advocates in keeping diseases politically prioritized and in securing resources for research, diagnostics, and treatments.
The Global Fight Against Lung Cancer: A Conversation with WHO's José Luis Castro
Q: From your perspective, should lung cancer be considered a global health issue given its mortality burden?
Yes, lung cancer deserves global health prioritization because it causes significant mortality and its burden is influenced by preventable factors like tobacco use and air pollution; addressing these root causes through policy can shift outcomes.
LCC Advances in ALK+ Cancer in Cantonese
Q: What is the role of surgery after targeted therapy in ALK-positive disease, given potential fibrosis and tissue changes?
Surgeons report that while fibrosis increases operative difficulty, many patients can still be operated on with careful planning; selection criteria and timing remain crucial to optimize outcomes.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Lung Cancer Considered

What is Lung Cancer Considered about and what kind of topics does it cover?

Listener-friendly overview: This show centers on thoracic oncology, with in-depth discussions of targeted therapies, immunotherapies, molecular testing, and real-world sequencing and testing challenges. Guests range from leading clinicians and researchers to patient advocates, delivering practical insights on trial data, biomarker-driven care, and how global practices influence care access. Episodes often explore testing gaps, perioperative decisions, and the evolving landscape of EGFR, ALK, ROS1, KRAS, and RET–driven NSCLC, plus reflections on career development and multidisciplinary collaboration. A standout angle is translating complex trial results into actionable clinical guidance while highlighting global disparities and pathways to i... more

Where can I find podcast stats for Lung Cancer Considered?

Rephonic provides a wide range of podcast stats for Lung Cancer Considered. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Lung Cancer Considered and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Lung Cancer Considered get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Lung Cancer Considered, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Lung Cancer Considered?

Rephonic provides comprehensive predictive audience data for Lung Cancer Considered, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Lung Cancer Considered have?

To see how many followers or subscribers Lung Cancer Considered has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Lung Cancer Considered?

These podcasts share a similar audience with Lung Cancer Considered:

1. Lung Cancer Update
2. Two Onc Docs
3. JTO Insights
4. JAMA Clinical Reviews
5. Conversations in Lung Cancer Research

How many episodes of Lung Cancer Considered are there?

Lung Cancer Considered launched 7 years ago and published 419 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Lung Cancer Considered?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Lung Cancer Considered?

Rephonic pulls ratings and reviews for Lung Cancer Considered from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Lung Cancer Considered?

Rephonic provides full transcripts for episodes of Lung Cancer Considered. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Lung Cancer Considered?

Recent guests on Lung Cancer Considered include:

1. Miguel Gonzalez Velez
2. Jorge Alatorre
3. Daniel Tan
4. Julia Rotow
5. Roy Herbst
6. Yun Fan
7. Zhengfei Zhu
8. Dongsheng Yue

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days